-transparent.png){kind=logo}
Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. 1995
Third Department of Internal Medicine, Okayama University Medical School, Japan.
Ten patients with non-insulin-dependent diabetes mellitus who were being treated with a sulphonylureal compound but whose glucose metabolism needed further improvement were given a combination of their usual sulphonylurea treatment and an alpha-glucosidase inhibitor. Treatment with the alpha-glucosidase inhibitor (0.6 mg/day), in addition to glibenclamide (7.5 mg/day in two patients; 5.0 mg/day in four; 2.5 mg/day in one) or tolbutamide (500 mg/day in three patients) for 4 weeks, improved hyperglycaemia after meals from 237-247 mg/dl to 192 mg/dl, and reduced glycosylated haemoglobin levels from 8.5-8.6% to 7.9% without causing hypoglycaemia.
Related Publications
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
January 1998,
The Medical journal of Australia,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
November 1995,
Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
January 1988,
Diabetic medicine : a journal of the British Diabetic Association,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
October 1988,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
January 1999,
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
February 1989,
Diabetes research (Edinburgh, Scotland),
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
January 1992,
Drugs,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
April 1991,
American heart journal,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
January 1991,
European journal of clinical pharmacology,
S Okada, and
K Ishii, and
S Tanokuchi, and
H Hamada, and
K Ichiki, and
Z Ota
January 1988,
European journal of clinical pharmacology,
